结构-活动关系研究,以开发二性作为特定物种的抗菌药物
Aramis J Pereira1, Huihua Xing1,2, Luana J de Campos1
1Department of Pharmaceutical Sciences, University of Nebraska Medical Center (UNMC), Omaha, NE 68198, USA.
Chemistry (Weinheim an der Bergstrasse, Germany)
|January 14, 2024
概括
两 (PA) 纳米结构通过破坏细菌膜显示出强大的抗菌活性. 结构-活性关系揭示了泽塔潜力和分区系数是影响抗葛兰阳性和葛兰阴性细菌疗效的关键因素.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 微生物学 微生物学
背景情况:
- 抗微生物两性 (PAs) 是多功能分子,具有破坏细菌膜和作为药物纳米载体的潜在应用.
- 由于抗菌素耐药性不断增加,新型抗菌剂的开发至关重要.
研究的目的:
- 为了确定33个PA的超分子结构-活性关系.
- 研究PA纳米结构对各种细菌菌株的抗菌活性和机制.
- 评估有前途的PA候选物的体外和体内疗效和毒性.
主要方法:
- 准备和表征33个类两性动物 (PAs).
- 评估纳米结构形态和抗微生物活性,对抗阳性 (如金黄色葡萄球菌) 和阴性 (如大肠杆菌, Pseudomonas aeruginosa, Acinetobacter baumannii) 细菌.
- 主要组件分析 (PCA) 以确定关键结构-活动驱动因素 (zeta潜力,LogP).
- 机械学研究包括膜透性,脱极化,泽塔潜力和完整性测试.
- 实验室哺乳动物细胞毒性评估.
- 在体内使用幼虫的治疗疗效研究.
主要成果:
- 确定了PA活动的关键贡献者:S. aureus的泽塔潜力和格兰氏阴性细菌 (P. aeruginosa > E. coli > A. baumannii) 的分区系数 (LogP).
- 阐明了涉及细菌膜破坏的作用机制.
- 对哺乳动物细胞的低毒性被证明是有效的候选物.
- 在体内模型中证实了治疗疗效.
结论:
- 阴离子PA纳米结构代表了开发新型纳米抗菌剂的有希望的平台.
- 超分子结构显著影响抗菌活性,提供了合理的设计方法.
- 这些发现支持PA作为传统抗生素的替代品的潜力.
更多相关视频
10:13Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
Published on: August 11, 2018
11.8K
12:02An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
Published on: November 2, 2016
12.1K
相关概念视频
Antimicrobial Proteins
994
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
994
Structure-Activity Relationships and Drug Design
726
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
726
